CAS 924473-59-6

3-methyl-N-(3-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)-1,2-oxazole-5-carboxamide

CAS: 924473-59-6

Formel: C₁₉H₁₄F₃N₃O₃

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 389.3280

Ref: IN-DA01EB1S

3-Methyl-N-(3-((3-(Trifluoromethyl)Phenyl)Carbamoyl)Phenyl)Isoxazole-5-Carboxamide

CAS: 924473-59-6

3-Methyl-N-(3-((3-(Trifluoromethyl)Phenyl)Carbamoyl)Phenyl)Isoxazole-5-Carboxamide

Reinheit: 99%

Molekulargewicht: 389.33g/mol

Ref: 54-PC108512

T56-LIMKi

CAS: 924473-59-6

T56-LIMKi

Reinheit: ≥98%

Molekulargewicht: 389.33g/mol

Ref: 54-BUP10697

T56-LIMKi

CAS: 924473-59-6

T56-LIMKi (T5601640) is a selective inhibitor of LIMK2.

Formel: C₁₉H₁₄F₃N₃O₃

Reinheit: 98.39% - 99.57%

Farbe und Form: Solid

Molekulargewicht: 389.33

Ref: TM-T3960

T56-LIMKi

CAS: 924473-59-6

Reinheit: 99%

Molekulargewicht: 389.099

Ref: 10-F864173

T56-LIMKi

CAS: 924473-59-6

T56-LIMKi is a peptide that belongs to the LIM domain family. It is an activator that can increase the phosphorylation of Akt, which is a protein involved in cell survival and protein synthesis. T56-LIMKi has been shown to inhibit ion channels, such as voltage-gated potassium channels. T56-LIMKi also inhibits proteins that are involved in receptor signaling pathways, such as G protein coupled receptors (GPCRs) and ligand-gated ion channels. This peptide has been used as a research tool for studying the interactions of proteins with each other and their role in cellular processes such as signal transduction.

Formel: C₁₉H₁₄F₃N₃O₃

Reinheit: Min. 95%

Molekulargewicht: 389.33 g/mol

Ref: 3D-ZLB47359